In human BL cells transcription of the NFATc1 gene is mainly driven by the P1 promoter, whereas P2 promoter activity is dominant in mouse BCL tumors and derived cell lines (Figures 4A, B). This evidence concerns the gene NFATC1 and Burkitt lymphoma.